Rainer Gawlick
At a glance: Rainer Gawlick is Director at Proto Labs (PRLB). Their latest SEC Form 4, filed Nov 4, 2026, reported a purchase of $49K. On file: 1 purchase line ($49K) and 0 sale lines ($0).
Disclosed holdings: about $3.0M of PRLB stock: 46,813 shares reported on their latest Form 4 (filed Nov 4, 2026), valued at the Nov 19, 2026 close of $63.38. This counts only PRLB shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Proto Labs Inc (PRLB)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Rainer Gawlick's InsiderPrint
4 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.
Reading this print: Almost only buys, trading about once a year, typically $74K a trade; often buys after the stock has fallen 15% or more.
- Bump outward: a purchase (4)
- Dent inward: a sale (0)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Gregory R. PageDirector · CTVA · 100% match
- Richard DouglasDirector · ALDX · 100% match
- John E. BachmanDirector · GO · 99% match
- Vincent J. AngottiCEO · TLPH · 98% match
- Marc ZennerDirector · OSPN · 98% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 4SEC | PRLBProto Labs Inc | Buy | 72046,813 held (+2%) | $68.18 | $49K | -7.0% |
- Buy
Director Rainer Gawlick bought $49K of PRLB at $68.18 — first open-market purchase in our records.
Follow Rainer Gawlick
Get one email when Rainer Gawlick files a new purchase or sale. Free.
At most one email a day about Rainer Gawlick, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.